Harvard Psychopharmacology A Master Class 2026

🧠 Harvard Psychopharmacology: A Master Class (2026)

📦 Course Details

• Size: 6.76 GB

• Contents: 19 Videos 🎥 | 19 VTT Subtitles 💬 | 17 PDFs 📄

• Target Audience: 👥 Best for psychiatrists, nurse practitioners, and primary care physicians who want key updates on advanced psychopharmacology and novel therapeutics.

📖 Overview

Harvard Psychopharmacology: A Master Class is a comprehensive, advanced educational program designed for prescribing clinicians seeking cutting-edge knowledge in psychiatric treatment. Originally held March 20–21, 2026, this course delves into the neurobiology of mental illness, novel therapeutics, and complex clinical scenarios. It provides evidence-based strategies for managing refractory depression, bipolar disorder, schizophrenia, and substance use disorders across diverse patient populations.

🎯 Learning Objectives

By completing this course, clinicians will be able to:

• Understand the underlying neurobiology of psychiatric disorders to inform targeted psychopharmacological interventions.

• Evaluate and implement advanced therapeutic strategies for difficult-to-treat conditions, including refractory depression and complex bipolar disorder.

• Assess emerging treatments, such as neuromodulation approaches, psychedelics for PTSD, and the role of Apps/AI in psychiatric care.

• Tailor psychopharmacologic treatments for specific populations, including geriatric, pediatric, perinatal, and substance use disorder patients.

📋 Course Topics

• Update on Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance

• Update on the Development of Antidepressants for Refractory Depression

• Treatment of Bipolar Disorders: Rational Polypharmacy and Bipolar Depression

• Psychopharmacology in Perinatal Mood and Anxiety Disorders

• Psychopharmacologic Approaches in Childhood and Adolescent Affective Disorders

• Panel Discussion 1 🗣️

• Current and Emerging Neuromodulation Approaches: Update for Prescribers

• Psychopharmacology in Geriatric and Neuropsychiatry Populations

• Therapeutic Approaches to the Difficult Patient: Difficult-to-Treat Depression

• Panel Discussion 2 🗣️

• Current Treatment for Schizophrenia: Prodrome, First Episode, Relapse, and New Treatment Possibilities

• Neurobiology and Treatment of Sleep in Psychiatric Disorders

• Apps and AI as Therapeutics 📱🤖

• Mechanisms of Psychedelics and Their Potential Treatment for PTSD

• Panel Discussion 3 🗣️

• Effective Treatment of Substance Use Disorders

• Anxiety Mechanisms, Treatment of Anxiety Spectrum Disorders & New Benzodiazepine Data

• The Status of Laboratory Testing to Predict Antidepressant Response: Problems and Promises

• Panel Discussion 4 🗣️